BioPeptidyne — Insights
Protocol guides, deep-science
& compound research.
All compound content in one place — practical protocol guides, market updates, peer-reviewed mechanism deep-dives, and sourcing analysis. Covering 17 articles across 7 categories.
17
Articles published
7
Categories covered
2026
Content season
SAFETY & RESEARCH
Peptides &
Cancer Risk Evidence, not hype
Cancer Risk Evidence, not hype
Safety & Research
Jul 2, 2026
Do Research Peptides Increase Cancer Risk? What the Evidence Actually Shows (2026)
Neither "peptides cause cancer" nor "peptides fight cancer" is well supported by current evidence. The growth-factor mechanism behind the concern, where human data actually exists, and practical risk-management guidance.
GUT-IMMUNE BARRIER
KPV
Research Guide NF-κB · PEPT1
Research Guide NF-κB · PEPT1
Gut-Immune Barrier
Jul 6, 2026
KPV: The Smallest, Smartest Anti-Inflammatory Peptide
KPV is the C-terminal tripeptide fragment of alpha-MSH — a receptor-independent anti-inflammatory tool. Covers the importin alpha-3 / NF-κB blockade mechanism, PepT1-targeted delivery, cross-system barrier evidence, and research-community dosing and stacking frameworks.
SKIN & HORMONAL BARRIER
KPV
for Women SKIN · GUT · HORMONES
for Women SKIN · GUT · HORMONES
Skin & Hormonal Barrier
Jul 6, 2026
KPV for Women: Why Your Skin Turns on You After 40
Reactive skin, sudden food sensitivities, and flares that seem to come out of nowhere are a common theme in research discussions around perimenopause. The gut-skin-hormone barrier connection, and how KPV fits into topical and systemic research protocols.
TIER LIST · METABOLIC
20 Fat-Loss
Compounds Ranked S-TIER TO F-TIER
Compounds Ranked S-TIER TO F-TIER
Tier List · Metabolic
Jul 6, 2026
20 Fat-Loss Compounds Ranked Worst to Best (No GLP-1s)
From a Phase 1 trial that ended in kidney toxicity to the FDA-approved gold standard for visceral fat — a complete tier-list breakdown of 20 non-GLP-1 fat-loss compounds, with mechanism, dosing, and safety flags for every single one.
LONGEVITY
NAD+
Cellular Aging -50% BY AGE 60
Cellular Aging -50% BY AGE 60
Longevity · Mitochondrial Health
Jul 7, 2026
NAD+ Falls 50% by Age 60: The Sirtuin Science Behind Cellular Aging
NAD+ is the obligate coenzyme for over 500 enzymatic reactions and the exclusive fuel for the sirtuin enzymes that maintain your epigenome. The CD38/PARP1/NAMPT mechanism behind the decline, and what the Yoshino 2021 human trial and Mills 2016 mouse study show about NMN and NR.
BIOMARKER GUIDE
Blood Panel
Before Peptides 15 markers mapped
Before Peptides 15 markers mapped
Protocol Guides
Jul 1, 2026
Blood Panel Before Peptides: The Complete Biomarker Guide (2026)
IGF-1, ApoB, hs-CRP, SHBG, Hematocrit and 12 more biomarkers mapped to specific research peptides — with reference ranges and the physiology behind each one, plus a suggested testing cadence.
DEEP DIVE
Why the Scale
Stops 6-9 month wall
Stops 6-9 month wall
Deep Dive
Jul 1, 2026
Why the Scale Stops: GLP-1 Research Plateaus & Peptide Failure Modes (2026)
Adaptive thermogenesis, receptor internalization, the Medication Reset Protocol, and the exact lab panel to identify why a Semaglutide, Tirzepatide, or Retatrutide protocol stalled.
PROTOCOL GUIDE
Beyond the
Injection LED philosophy
Injection LED philosophy
Protocol Guides
Jul 1, 2026
Beyond the Injection: GLP-1 Protocol Optimization & Rebound Prevention (2026)
API sourcing (503A vs 503B), baseline labs, the Lowest Effective Dose philosophy, the Medication Reset Protocol, and SURMOUNT-5 head-to-head data for Semaglutide, Tirzepatide and Retatrutide.
NUTRITION
10 Synergy
Foods L-cell signaling
Foods L-cell signaling
Nutrition
Jul 1, 2026
10 Foods That Amplify GLP-1 Results: The Synergistic Nutrition Protocol (2026)
Fatty fish, legumes, Greek yogurt, avocados and more — the specific foods that trigger L-cell GLP-1/PYY signaling and SCFA production, with the mechanism behind each one.
MASTERCLASS
Retatrutide
Dosing Blast & Cruise
Dosing Blast & Cruise
Protocol Guides
Jul 1, 2026
The Retatrutide Masterclass: Titration, Blast-and-Cruise & Side Effect Protocol (2026)
The 17-week titration schedule, the 8mg "sweet spot" vs 12mg ceiling, split-dosing pharmacokinetics, taurine/magnesium side-effect mitigation, the Tirzepatide switch protocol, and the Blast-and-Cruise maintenance strategy.
GLP-1 COMPARE
Sema · Tirze
Retatro −28.7% Phase 3
Retatro −28.7% Phase 3
Comparisons
May 4, 2026
Semaglutide vs Tirzepatide vs Retatrutide 2026: The Definitive Comparison Guide
Three generations of GLP-1 peptides compared side by side — with TRIUMPH-4 Phase 3 data (Retatrutide −28.7%), a full comparison table, reconstitution difficulty analysis, and selection logic from a competitive athletics coach.
TRIPLE RECEPTOR
Retatrutide
2026 −28.7% Phase 3
2026 −28.7% Phase 3
Deep Dive
May 4, 2026
Retatrutide 2026: Triple-Receptor Science, TRIUMPH-4 Phase 3 Data & Research Protocol Guide
TRIUMPH-4 confirmed: 12mg −28.7% over 68 weeks. Beyond the weight number — six metabolic benefits including WOMAC joint pain 75.8%, hepatic fat reduction, cardiovascular lipids, and the unique Glucagon-driven basal metabolic rate effect that Sema and Tirze can't replicate.
POST GLP-1
Metabolic
Recovery 67% regained in 12 mo
Recovery 67% regained in 12 mo
Metabolic Recovery
May 5, 2026
Post-GLP-1 Metabolic Recovery: 67% of Weight Loss Regained in 12 Months — How to Stay in the Other 33%
STEP 1 extension study confirmed: the average researcher regains 67% of weight lost within one year of stopping. A systematic guide covering Ghrelin rebound mechanics, 4–8 week tapering strategy, the muscle-first defense, competition-grade nutrition, and the BioPeptidyne data tracking alert system.
STACK
BPC-157
+TB-500 RECOVERY 2026
+TB-500 RECOVERY 2026
Protocol Guides
May 4, 2026
BPC-157 & TB-500 Stack Guide 2026: The Science Behind Sports Injury Recovery
When a single peptide isn't enough. Deep-dive into the complementary mechanisms of BPC-157 (local angiogenesis) and TB-500 (systemic cell migration), with cycle planning logic, PPL training adjustments, and 4 expert FAQs.
ANTI-AGING · BEAUTY
GHK-Cu
Reverse Aging 4,000 GENES · -56% WRINKLES
Reverse Aging 4,000 GENES · -56% WRINKLES
Anti-Aging · Beauty
May 5, 2026
GHK-Cu Anti-Aging & Beauty Guide: Rewinding 4,000 Genes Back to Youth
Your body hasn't forgotten how to repair itself — it's lost the signal. GHK-Cu declines 60% between age 20 and 60. Covers the 4,000-gene DNA reset, 67% ATP upgrade, 56% wrinkle reduction, 80% DHT blockade for hair loss, and the 12/4 cycling protocol that prevents receptor adaptation.
BIOREGENERATION
GHK-Cu
Clinical Guide 4,000 GENES · 12/4 PROTOCOL
Clinical Guide 4,000 GENES · 12/4 PROTOCOL
Bioregeneration
May 5, 2026
GHK-Cu Clinical Practice Guide: LRP1 Signaling, 4,000 Genes & the 12/4 Cycle Protocol
GHK-Cu concentrations fall 60% between age 20 and 60. This guide maps the LRP1 4-step cascade, the three biological failures it resolves (ATP shortage, inflammation, insulin resistance), cross-organ applications across four systems, and the cycling protocol that prevents receptor downregulation.
GH AXIS
HGH · CJC-1295
Ipamorelin · IGF-1 4-TIER FRAMEWORK
Ipamorelin · IGF-1 4-TIER FRAMEWORK
Deep Analysis
May 5, 2026
HGH vs CJC-1295/Ipamorelin vs IGF-1: The 4-Tier GH Axis Intervention Framework
Pituitary ceiling, Somatostatin brake mechanics, pulsatile vs. continuous lipolysis efficiency, the gold-standard Mod GRF + Ipamorelin stack, and the 86–94% cross-tier suppression trap. Covers all four intervention tiers with three goal-driven protocol profiles.
COMPARISON
BPC-157
vs TB-500 VASCULAR · CELLULAR
vs TB-500 VASCULAR · CELLULAR
Comparisons
May 6, 2026
BPC-157 vs TB-500: Mechanisms, Differences & When to Stack
They're both repair peptides — but they operate on entirely different biological axes. BPC-157 builds vascular infrastructure via VEGFR2 and FAK-Paxillin; TB-500 mobilizes cellular repair crews via actin regulation. Comparison table, tissue targeting guide, and injection protocol logic.
WEIGHT LOSS 2026
King of
Peptides −28.7% · FAT MOBILIZATION
Peptides −28.7% · FAT MOBILIZATION
Fat Loss Strategy
May 6, 2026
The King of Peptides for Weight Loss 2026: Retatrutide, AOD9604 & the Complete Fat-Loss Stack
Retatrutide's triple-receptor mechanism delivers −28.7% body weight. But the real system goes deeper: AOD9604 unlocks adipocyte mobilization, SLU-PP-332 resets metabolic enzymes, and MOTS-c forces mitochondrial fat-burning. Three systems, one strategic stack.
PROTOCOL
配製
GUIDE 2026
Protocol Guides
May 4, 2026
Peptide Reconstitution Guide 2026: Dilution Math, Step-by-Step Protocol & Storage Rules
Written by a nursing research graduate with 10+ years of competitive athletics coaching. Covers equipment setup, the 3-step wall-flow technique, dosage conversion formulas, and expert storage rules for BPC-157, GHK-Cu, Semaglutide and more.
Deep Science
Peer-reviewed mechanism reviews with PubMed citations — formerly the Research Library.
REPAIR · ANGIOGENESIS
BPC-157
Master Regulator VEGF · FAK-PAXILLIN · GI
Master Regulator VEGF · FAK-PAXILLIN · GI
Deep Science
Apr 26, 2026
BPC-157: The Master Regulator of Systemic Repair
Comprehensive mechanism review covering VEGF/VEGFR2 angiogenesis, FAK-paxillin tendon remodelling, gastrointestinal cytoprotection, and NO system modulation — with 15 PubMed citations from the Sikiric laboratory series.
GENOMICS · LONGEVITY
GHK-Cu
Genomic Reset 4,000 GENES · SP1 AXIS
Genomic Reset 4,000 GENES · SP1 AXIS
Deep Science
Apr 26, 2026
GHK-Cu: Genomic Modulation and Rejuvenation Science
How a single copper tripeptide resets over 4,000 aging-associated genes via Sp1 transcription factor binding. Covers LRP1 receptor cascade, collagen ECM rebuilding, Wnt/β-catenin hair follicle activation, and DHT pathway inhibition.
TISSUE ENGINEERING
GHK-Cu
Regenerative WOUND · SCAFFOLD · ECM
Regenerative WOUND · SCAFFOLD · ECM
Deep Science
Apr 26, 2026
GHK-Cu: Regenerative Potential in Tissue Engineering
From wound-healing scaffolds to hair follicle bioreactors — how GHK-Cu integrates into biomaterial matrices to accelerate tissue regeneration. Covers ECM remodelling enzymes, MMP regulation, and clinical wound healing data.
GLP-1 PHARMACOLOGY
Semaglutide
Ozempic / Wegovy −15.3% STEP 1 · RECEPTOR
Ozempic / Wegovy −15.3% STEP 1 · RECEPTOR
Deep Science
May 4, 2026
Semaglutide (Ozempic · Wegovy): GLP-1 Receptor Pharmacology & Clinical Weight Loss Data
The pharmacokinetics behind once-weekly dosing: fatty acid albumin binding, GLP-1 receptor signalling cascade, central and peripheral appetite suppression, STEP 1–8 trial data, and mechanistic comparison against tirzepatide and retatrutide.
DUAL RECEPTOR
Tirzepatide
Mounjaro GIP + GLP-1 · SURMOUNT
Mounjaro GIP + GLP-1 · SURMOUNT
Deep Science
May 4, 2026
Tirzepatide (Mounjaro · Zepbound): Dual GIP+GLP-1 Receptor Pharmacology & SURMOUNT Data
Why dual-receptor agonism outperforms single GLP-1 targeting: GIP receptor's role in adipose lipid uptake, the synergistic insulin secretion mechanism, SURMOUNT-1 −22.5% data, and the pharmacokinetic half-life profile enabling weekly dosing.
TRIPLE RECEPTOR
Retatrutide
Phase 2 Science GLP-1 · GIP · GCG
Phase 2 Science GLP-1 · GIP · GCG
Deep Science
May 4, 2026
Retatrutide: Triple GLP-1/GIP/Glucagon Receptor Agonism & Phase 2 Weight Loss Data
The first compound to simultaneously engage all three incretin/glucagon receptors: mechanistic breakdown of GCG receptor-driven BMR elevation, Phase 2 −24.2% data at 48 weeks, and the pharmacological basis for superior adipose tissue lipolysis.
LONGEVITY · SIRTUINS
NAD+
Longevity SIRT1-7 · NMN · AGING
Longevity SIRT1-7 · NMN · AGING
Deep Science
May 4, 2026
NAD+ and Aging: Cellular Energy Decline, Sirtuin Activation & NMN Research
NAD+ declines ~50% from age 20 to 70, directly impairing SIRT1-7 deacetylase activity and PARP-mediated DNA repair. Deep-dive into the salvage pathway, NMN vs NR precursor comparison, and the case for IV/IM delivery in rapid intracellular repletion models.
More articles coming in 2026
Upcoming topics include GLP-1 sourcing guides, longevity peptide spotlights, and the 2026 market landscape.
For compound reference data, browse all 26 entries in the Encyclopedia.
Upcoming topics
Protocol Guides
Reconstitution · Dosing · Storage
Market Trends
GLP-1 · Longevity · 2026
Compound Comparisons
Sema vs Tirze vs Retatro
Product Spotlights
New catalog additions
Sourcing & Quality
HPLC · CoA · Purity